BioPharm America™ 2011—4th Annual International Partnering Conference
07 September 2011 - 09 September 2011
BioPharm America™ is where biotech industry partnerships get started. This three-day conference provides a proven and highly productive format for establishing new business relationships. Meet face-to-face with biotech and pharma executives from around the world to identify and enter strategic relationships. Equipped with partneringONE®, the world’s leading web-based partnering system for the life science industry, BioPharm America is the only event in North America based on the same reputable formula as EBD Group’s acclaimed European events BIO-Europe® and BIO-Europe Spring®. In 2010, BioPharm America attracted 850 delegates from 565 companies who participated in 2,550+ scheduled one-to-one meetings.
Boston, MA, USA
http://www.ebdgroup.com/bpa/index.php
5th Annual ELRIG Drug Discovery Conference
07 September 2011 - 08 September 2011
As with our highly successful meeting in 2010, attendees will hear world class speakers discussing the challenges and opportunities facing the drug discovery scientist. The scientific sessions will be complemented by a poster session, a growing vendor exhibition with over 85 exhibitors and a number of training workshops.
Manchester Central, UK
http://www.elrig.org
Pharma ChemOutsourcing Conference & Exhibition
12 September 2011 - 15 September 2011
Small Molecule Biotech Chemist Sourcing Focus
The Conference is Especially Geared to Your Unique Sourcing Needs
High Value Networking
Attended by the Highest Ratio of Pharmaceutical Attendees of Any Chemistry Show
High Value Conference Program Available Nowhere Else
Hear from 120 Pharma Company Chemistry Speakers Who Do Your Job
Exhibition is Strictly Limited to 100 Booths
85% of 2010 Exhibitors Have Returned for Two Reasons - NEW BUSINESS & THEIR CLIENTS ATTEND
Ocean Place Resort - Long Branch, NJ, USA
http://www.chemoutsourcing.com/
Poorly soluble drugs workshop
15 September 2011
The APGI (Association de Pharmacie Galénique Industrielle) is organizing for the first time a workshop dedicated to the appropriate formulation of poorly water-soluble drugs. During the one day event, oral and poster presentations from academia and industry as well as practical demonstrations (in small groups) are foreseen.
The University of Lille, College of Pharmacy, 3 Rue du Professeur Laguesse, 59006 Lille, France
http://www.apgi.org/2011_WS/
20TH HELSINKI DRUG RESEARCH CONGRESS
18 September 2011 - 20 September 2011
This conference presents an update of modern and emerging ADMET tools for drug discovery and delivery. Drug discovery and drug delivery are facing major challenges and these fields are in rapid transition. FDA and EMEA have addressed the need for predictive tools that reduce the attrition rate of the drug candidates in the clinical phases. Such tools are critical in the selection of the lead compounds with proper ADMET and other features, while new drug delivery systems are essential in improving the ADME features of gene medicines, anti-cancer drugs, drugs acting on the CNS and retina. Nanotechnology will provide new opportunities for tool development in drug delivery and ADMET research. The new and emerging methods are expected to augment the discovery and development of new drugs and drug delivery systems.
University of Helsinki, Finland
http://www.ddtc.helsinki.fi/hdr2011/HDR2011/HDR2011.html
3rd China Clinical Trials Outsourcing Congress
19 September 2011 - 20 September 2011
The 3rd China Clinical Trials Outsourcing Congress will focus on how to meet the challenges of conducting clinical trials in China and assessing the challenges and advantages of partnering with regional CROs versus setting up operations in China. The programme will focus on issues such as regulatory procedures, patient recruitment and retention, logistics and data management through case studies and keynote presentations from industry experts all actively involved in conducting clinical studies in China.
The Sheraton Skyline Hotel London Heathrow, London, UK
http://www.globalengage.co.uk/events/
Biomarkers in Clinical Trials
19 September 2011 - 20 September 2011
SMi is proud to present their 3rd annual conference on Biomarkers in Clinical Trials. With the 2011 event aiming to explore the use of biomarkers in Cancer drug development.
Concerns over efficacy, cost, and drug safety have stimulated a need for personalized medicine; and to increase the predictability of clinical research to reduce development cost and time. The use of biomarkers in no longer limited to whether a patient will responsd to a treatment, but has extended to aid drug development in all its forms.
As a result biomarkers have now gained significant attention in the R&D process. Which are seen as an emerging but lucrative segment that is opening up new development opportunities, and attracting much commercial interest
Copthorne Tara Hotel, Central London, UK
http://www.smi-online.co.uk/events/overview.asp?is=4&ref=3697
5th Annual Pain Therapeutics Summit
20 September 2011 - 21 September 2011
This conference will provide attendees with thoughtful insight from key industry leaders and academic researchers concerning cutting edge drug discovery science, preclinical development trends, analysis of key clinical-stage pain therapies and newly marketed products. We will highlight the most important developments in recent years in the field, including new research in CGRP antagonists, NGF antagonists, Nav 1.7 antagonists, new research in biologic therapies and the genetic component of pain, abuse-resistant opioids, analysis of FDA’s REMS program and a plethora of other topics.
San Francisco, CA, USA
http://www.paintherapeuticsummit.com
Predictive in Vitro Models
21 September 2011 - 22 September 2011
Predictive In Vitro Models gathers industry leaders to discuss how to increase pre-clinical predictive capability.
Boston Conference and Exhibition Centre, MA
http://invitro-models.com
The 4th CNS Partnering & Deal Making Conference
22 September 2011 - 24 September 2011
The 4th CNS Partnering & Deal Making Conference is a CNS Diseases partnering and business development conference that gives global biotechnology and pharmaceutical companies an opportunity to network with high-level executives from top pharma and various biotech/pharmaceutical companies, as well as explore potential collaborations, and learn about relevant CNS Disease issues and partnerships that will affect the industry.
Hotel Kabuki,San Francisco, CA, USA
http://www.gtcbio.com/index.php?option=com_conference&file=home&cn=4th%20CNS%20Partnering%20and%20Deal-making&cid=38
Quantum Science Symposium-2011
26 September 2011 - 27 September 2011
Applications of Physical & Chemical Methods in Biological Systems'
777 Memorial Drive at Courtyard Marriott, Cambridge, Massachusetts 02139 USA
http://www.expressgenes.com/Quantum%202011/main.html
Pharmaceutical Amorphous Materials 2011
27 September 2011 - 28 September 2011
The conference is being held to explore the development, optimisation, engineering, stability and application of amorphous materials as an alternative solution to overcoming negative drug attributes during solid state development by improving:
Solubility, Dissolution, Stability, Delivery and Bioavailability
tbc. Amsterdam, The Netherlands
http://www.pharmaamorphous.com/Event.aspx?id=508476
Pharmaceutical Co-Crystals
27 September 2011 - 28 September 2011
This year’s conference will not only focus on the characterising, optimising, engineering and application of co-crystals but exclusive to this year:
EXPLORE the latest technological developments
BRAND NEW CASE STUDIES covering previously unheard material on:
co-crystal scale up, from research to manufacture from industry perspective
co-crystal control through formulation stages using novel methods and techniques
co-crystallisation from solution and solid state chemistry
tbc Amsterdam, The Netherlands
http://www.pharmacocrystals.com/Event.aspx?id=508454
Generics and Biosimilars Strategies EMEA
27 September 2011 - 29 September 2011
The inaugural Generics and Biosimilars Strategies EMEA conference is a unique business and networking opportunity for CEOs and Senior Executives keen to implement profitable and sustainable generics and biosimilars strategies.
Istanbul, Turkey
http://www.generics-emea.com/
KOL Liaison and MSL Best Practice
28 September 2011 - 29 September 2011
Following the tremendous successes of our KOL/MSL conferences in London, Munich and Stockholm, SMi presents its KOL Liaison and MSL Best Practice conference, which will focus on the increasingly varied role of MSLs, from their traditional function working with KOLs, to associated role challenges and in Medical Affairs in general.
Copthorne Tara Hotel, London, UK
http://www.smi-online.co.uk/events/overview.asp?is=4&ref=3722